Unilever launches $120m venture with Genom...Under the $120m deal, Genomatica and Unilever will scale plant- and waste-based alternative to palm oil and fossil fuels. more ➔
Roche obtains special authorisation for bi...Roche obtained from European Medicine Agency (EMA) a special authorization (conditional approval) for new bispecific antibody Lunsumio for treatment of relapsed or refractory follicular (R/R) lymphoma … more ➔
Andera Partners, Imcheck therapeutics, Kurma, marseille, Pfizer, wellington French ImCheck get´s a USD103m check by P... ImCheck Therapeutics located in Marseille, France, announced today the close of a EUR 96 million (USD 103 million) financing, co-led by Earlybird and Andera Partners. Kurma Partners, Eurazeo, Gimv, … more ➔
$50m for London CHARM Therapeutics for dee... CHARM Therapeutics launches with a $50 million Series A financing to transform structure-based drug discovery using its proprietary DragonFold AI technology. more ➔
Biotalys first proteinbased biocontrol s... Based on data from the latest trials in grapes across vineyards in diverse climates throughout California and New York, Biotalys’ biocontrol product Evoca provided superior preventative control of Botrytis … more ➔
Andera Partners, Heart, Hypertension, investment, Paris, Philadelphia, Rothschild, Venture Capital Andera Partners co-leads $118m Series B of... Andera Partners, Paris based European private equity player, announced on Wednesday that, together with RA Capital Management, it is leading an oversubscribed and up-sized $118m Series B financing for … more ➔
bioeconomy, circular economy, circularity, sustainable, Vamos, Wales, waste to value From waste to sugar – demonstration... The South Wales-based demonstration plant "VAMOS" that generates industrial biotechnology sugars and other recycled material streams from the paper and card in mixed household waste has come … more ➔
Covid-19International Vaccine Institute – IV... The International Vaccine Institute, IVI, which is associated with the WHO and UN, will locate its European office in Stockholm. To date, the institute is only located in the host country of South … more ➔
Abliva, disease, mitochondria, NeuroVive, Sweden, Ukraine Abliva decides on a SEK200m financing to f...The financing (around €19m) shall fully fund the commencement of a potentially pivotal/registrational Phase 2/3 study for KL1333 and its progression to the outcome of a key interim analysis. more ➔
Transine Therapeutics Ltd closes £13.7m s...Transine Therapeutics Ltd has added £4.6m from lead investor Epidarex Capital and the Dementia Discovery Fund (DDF) to its £9.1m seed funding led by Takeda Ventures and DDF. more ➔
